News25/Ratings0
News · 26 weeks42+50%
2025-12-212026-06-14
Mix4290d
- SEC Filings29(69%)
- Insider13(31%)
Latest news
25 items- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- INSIDERDirector Schmid John P. converted options into 6,030 shares, increasing direct ownership by 19% to 37,652 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- INSIDERDirector Orwin John A converted options into 6,030 shares, increasing direct ownership by 57% to 16,695 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- INSIDERDirector Renton Hollings converted options into 6,030 shares, increasing direct ownership by 121% to 10,995 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECAnaptysBio Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - ANAPTYSBIO, INC (0001370053) (Filer)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECAnaptysBio Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year8-K - ANAPTYSBIO, INC (0001370053) (Filer)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SECSEC Form 144 filed by AnaptysBio Inc.144 - ANAPTYSBIO, INC (0001370053) (Subject)
ANABV FAQ
4 questionsWhere does ANABV stock trade?
AnaptysBio Inc. (ANABV) is listed on NASDAQ.What sector and industry is ANABV in?
AnaptysBio Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to ANABV?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ANABV side-by-side with any of them on Quantisnow.How can I track ANABV on Quantisnow?
Quantisnow aggregates AnaptysBio Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ANABV to receive live email and push alerts on every new disclosure.